Screening for dementia - Is it a no brainer?

C. Fox, L. Lafortune, Malaz Boustani, T. Dening, G. Rait, C. Brayne

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

As people are living longer, dementia is becoming a significant issue for society. Dementia is now recognised as a major concern in society, and the numbers of people estimated to have dementia in the UK population appear to have stabilised at around 700,000. Globally, 35.6 million people are estimated to meet criteria for dementia, a number predicted to double every 20 years. Given the absence of treatments that significantly alter the natural history of the clinical syndrome of dementia, there has been increased emphasis on early diagnosis, with research exploring assessment tools and biomarkers that might predict with certainty a particular clinical outcome. At the same time, there has been pressure to focus on biomedical profiles, which assume a very close link between the pathobiology and the manifest clinical syndrome.

Original languageEnglish
Pages (from-to)1076-1080
Number of pages5
JournalInternational Journal of Clinical Practice
Volume67
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Dementia
Early Diagnosis
Biomarkers
Pressure
Research
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Screening for dementia - Is it a no brainer? / Fox, C.; Lafortune, L.; Boustani, Malaz; Dening, T.; Rait, G.; Brayne, C.

In: International Journal of Clinical Practice, Vol. 67, No. 11, 11.2013, p. 1076-1080.

Research output: Contribution to journalArticle

Fox, C, Lafortune, L, Boustani, M, Dening, T, Rait, G & Brayne, C 2013, 'Screening for dementia - Is it a no brainer?', International Journal of Clinical Practice, vol. 67, no. 11, pp. 1076-1080. https://doi.org/10.1111/ijcp.12239
Fox, C. ; Lafortune, L. ; Boustani, Malaz ; Dening, T. ; Rait, G. ; Brayne, C. / Screening for dementia - Is it a no brainer?. In: International Journal of Clinical Practice. 2013 ; Vol. 67, No. 11. pp. 1076-1080.
@article{4ee565d65994498f8596d92fcf888a79,
title = "Screening for dementia - Is it a no brainer?",
abstract = "As people are living longer, dementia is becoming a significant issue for society. Dementia is now recognised as a major concern in society, and the numbers of people estimated to have dementia in the UK population appear to have stabilised at around 700,000. Globally, 35.6 million people are estimated to meet criteria for dementia, a number predicted to double every 20 years. Given the absence of treatments that significantly alter the natural history of the clinical syndrome of dementia, there has been increased emphasis on early diagnosis, with research exploring assessment tools and biomarkers that might predict with certainty a particular clinical outcome. At the same time, there has been pressure to focus on biomedical profiles, which assume a very close link between the pathobiology and the manifest clinical syndrome.",
author = "C. Fox and L. Lafortune and Malaz Boustani and T. Dening and G. Rait and C. Brayne",
year = "2013",
month = "11",
doi = "10.1111/ijcp.12239",
language = "English",
volume = "67",
pages = "1076--1080",
journal = "International Journal of Clinical Practice",
issn = "1368-5031",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Screening for dementia - Is it a no brainer?

AU - Fox, C.

AU - Lafortune, L.

AU - Boustani, Malaz

AU - Dening, T.

AU - Rait, G.

AU - Brayne, C.

PY - 2013/11

Y1 - 2013/11

N2 - As people are living longer, dementia is becoming a significant issue for society. Dementia is now recognised as a major concern in society, and the numbers of people estimated to have dementia in the UK population appear to have stabilised at around 700,000. Globally, 35.6 million people are estimated to meet criteria for dementia, a number predicted to double every 20 years. Given the absence of treatments that significantly alter the natural history of the clinical syndrome of dementia, there has been increased emphasis on early diagnosis, with research exploring assessment tools and biomarkers that might predict with certainty a particular clinical outcome. At the same time, there has been pressure to focus on biomedical profiles, which assume a very close link between the pathobiology and the manifest clinical syndrome.

AB - As people are living longer, dementia is becoming a significant issue for society. Dementia is now recognised as a major concern in society, and the numbers of people estimated to have dementia in the UK population appear to have stabilised at around 700,000. Globally, 35.6 million people are estimated to meet criteria for dementia, a number predicted to double every 20 years. Given the absence of treatments that significantly alter the natural history of the clinical syndrome of dementia, there has been increased emphasis on early diagnosis, with research exploring assessment tools and biomarkers that might predict with certainty a particular clinical outcome. At the same time, there has been pressure to focus on biomedical profiles, which assume a very close link between the pathobiology and the manifest clinical syndrome.

UR - http://www.scopus.com/inward/record.url?scp=84886720705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886720705&partnerID=8YFLogxK

U2 - 10.1111/ijcp.12239

DO - 10.1111/ijcp.12239

M3 - Article

VL - 67

SP - 1076

EP - 1080

JO - International Journal of Clinical Practice

JF - International Journal of Clinical Practice

SN - 1368-5031

IS - 11

ER -